Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azilect Tablets Long-term Safety Survey in Parkinson's Disease
jRCT1080224120Completed
- Sponsor
- Takeda
- Start
- Oct 2018
- Modality
- Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of rasagiline in Parkinson's disease (PD), sponsored by Takeda. Primary endpoint: Long-term safety of rasagiline. Started Oct 2018; status: completed.
02
Drugs
rasagiline
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on jRCT1080224120.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1080224120.